Artal Group S.A. Accelerate Diagnostics, Inc Transaction History

Artal Group S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$7.04 - $11.7 $3.01 Million - $5 Million	-427,500 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$9.98 - $18.04 $1.59 Million - $2.87 Million	-159,000 Reduced 27.11%	427,500 $4.56 Million
Q2 2020 Aug 14, 2020	SELL	$7.49 - $15.16 $101,115 - $204,660	-13,500 Reduced 2.25%	586,500 $8.89 Million
Q4 2019 Feb 13, 2020	BUY	$14.6 - $18.13 $1.46 Million - $1.81 Million	100,000 Added 20.0%	600,000 $10.1 Million
Q3 2019 Nov 14, 2019	BUY	$16.62 - $23.92 $831,000 - $1.2 Million	50,000 Added 11.11%	500,000 $9.29 Million

Q2 2019 Aug 09, 2019	SELL	$17.79 - $22.88 $889,500 - $1.14 Million	-50,000 Reduced 10.0%	450,000 $10.3 Million
Q4 2017 Feb 09, 2018	BUY	$18.0 - $30.0 $5.4 Million - $9 Million	300,000 Added 150.0%	500,000 $13.1 Million
Q3 2017 Nov 08, 2017	BUY	$21.1 - $25.15 $4.22 Million - $5.03 Million	200,000	200,000 $4.49 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $114M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.